Navigation Links
Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke
Date:10/20/2010

By E.J. Mundell
HealthDay Reporter

WEDNESDAY, Oct. 20 (HealthDay News) -- The drug Pradaxa has been approved by the U.S. Food and Drug Administration to help prevent stroke in people with a type of abnormal heart rhythm called atrial fibrillation.

The drug may prove a new option for patients who now use standard blood thinners such as warfarin to control the heart condition.

More than 2 million Americans have atrial fibrillation, which occurs when the heart's two upper chambers beat quickly and out of sync, the FDA said Wednesday in a news release.

Pradaxa (dabigatran) is an anti-clotting drug that inhibits an enzyme involved in blood clotting. Clinical studies of the drug found that when compared with warfarin, people with atrial fibrillation had fewer strokes on Pradaxa than those on warfarin, the FDA said.

One such trial was presented in February at the American Stroke Association annual meeting in San Antonio. It included more than 3,600 patients with atrial fibrillation and a previous stroke who were randomly chosen to receive warfarin, a low dose of Pradaxa (110 milligrams) twice a day or a higher dose (150 mg) of Pradaxa twice a day for about two years.

The rate of stroke or transient ischemic attack (TIA, often called "mini- stroke") in those taking warfarin was about 2.7 percent a year and 2.3 percent a year for those taking Pradaxa, not a significant difference.

However, the lower dose of Pradaxa caused less bleeding and was easier to manage than warfarin, a famously difficult drug to administer and monitor.

"In contrast to warfarin, dabigatran is given in a fixed dose twice daily independent of body weight, sex, food, whatever, and you don't need to monitor the coagulation system," study author Dr. Hans-Christoph Diener, chairman of neurology at University Hospital in Essen, Germany, said during a news conference held during the meeting.

"In patients who already had a t
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy
2. FDA Approved Diabetes Drug Despite Hints at Cancer Risk
3. Former Bank Negotiator Turns On Bank and is Approved by the Department of Real Estate
4. BioCosmetic Center Utilizes FDA Approved Fractional Laser Treatment for Stretch Marks
5. Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation
6. Kinnser Software Supports HH CAHPS Survey Data Export to Three Approved HH CAHPS Survey Vendors
7. Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus
8. Expert Approved: FatWallet Guides Mother's Day Shoppers to the Best Deals Online
9. Parent Tested Parent Approved Media Announces their Winning Products for the Summer 2010 Campaign
10. doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions
11. U.S. FDA Adds 25 New Firms to Import Alert for Promotion of Unapproved New Drugs According to FDAImports.com, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke
(Date:9/20/2014)... 20, 2014 Ticket Down is ... . This popular ticket exchange is offering their customer ... The 2015 schedule of tours is beginning to fill up. ... their plans to hit the road, including 21-year-old pop superstar, ... the “Honeymoon Tour,” which will take her to 25 cities ...
(Date:9/20/2014)... 20, 2014 On Monday, September 22, ... pediatric cancer research grant from Hyundai Hope on Wheels ... Children’s Hospital located on 11234 Anderson St., in Loma ... Kimberley Payne, Associate Professor at Loma Linda University and ... leukemia in children. , Loma Linda University ...
(Date:9/20/2014)... 20, 2014 The print component ... edition of the Calgary Herald, with a circulation ... of 270,000. The digital component is distributed nationally ... a network of top news sites and partner ... campaign, visit http://www.worklifebalanceinfo.ca . , The publication ...
(Date:9/20/2014)... -- The avian flu that killed 160 harbor seals ... respiratory drops and therefore poses a potential threat to ... human illnesses have been linked to the harbor seal ... discovered natural mutations to the avian H3N8 seal virus ... in droplets. Current seasonal flu vaccines wouldn,t help ...
(Date:9/20/2014)... season is coming soon. The high-end fashion designer BellasDress is ... . A lot of sophisticated women like its new items. ... for its high quality clothes. Now, each of its elegant ... 71 percent off. , The company’s cocktail dress assortment ... many fashionable colors. Mary, the company’s sales manager, believes that ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2
... Commitment to Active Listening , ROCHESTER, ... Tomaino specializes in cutting-edge shoulder procedures including everything ... a reversed shoulder replacement that relieves pain, restores ... is also adept at the practice of active ...
... another reason for people to watch their blood pressure, ... that increased blood pressure in older adults is directly ... already high blood pressure. This means that stressful situations ... think clearly. , Dr. Jason Allaire, an assistant professor ...
... LONDON, Dec. 15 The immunoassay diagnostics market is ... It is being challenged by a number of factors ... the heightened popularity of molecular tests in areas like ... propelling companies to develop novel assays and differentiate themselves ...
... Dec. 15 Roche announced today that its,innovative ... allowing,it to be sold for clinical use in ... Test, v2.0 utilizes a unique design to,simultaneously amplify ... genome.,This approach provides reliable test results even when ...
... possible new therapeutic target for pancreatic cancer, the most ... the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," ... Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in ... fruit fly, Drosophila melanogaster, at the Mayo Clinic College ...
... featured in an upcoming episode. , ... Deerfield Beach, FL (PRWEB) December ... announce that Gradient Medical, LLC will be featured in an upcoming episode ... Today., , ,Pain is a national public healthcare crisis. It is estimated ...
Cached Medicine News:Health News:Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care 2Health News:Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care 3Health News:Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care 4Health News:Development of Novel Assays Vital for the European Immunoassay Diagnostics Market 2Health News:Development of Novel Assays Vital for the European Immunoassay Diagnostics Market 3Health News:New Roche Dual Target HIV-1 Test Approved for Use in European Union 2Health News:New Roche Dual Target HIV-1 Test Approved for Use in European Union 3Health News:Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer 2Health News:"The Economic Report" Show to Feature Gradient Medical, LLC 2
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
(Date:9/19/2014)... and ORLANDO, Fla. , Sept. 19, ... therapy continues to grow, with the publication of two ... in Otolaryngology – Head and Neck Surgery ... worsening of both objective and subjective measures of sleep ... Inspire therapy for the reduction in obstructive sleep apnea ...
(Date:9/19/2014)... 2014  Over 200 runners participated in the fifth ... Radiation Oncology Institute (ROI), hosted by Radiation Business Solutions. This ... in San Francisco.  "Donations are still ... Radiation Business Solutions, "but at this point, through ... for the ROI this year. This surpasses last year,s ...
Breaking Medicine Technology:Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
... Rochester Medical Corporation (Nasdaq: ROCM ) today announced that it is ... healthcare alliance. , , , ... with more than 800 suppliers and Rochester Medical is one of 38 ... outstanding management of Premier agreements and drive toward the mutual goal of ...
... June 22 Hospira, Inc. (NYSE: HSP ... it has received U.S. Food and Drug Administration (FDA) approval ... g vials.  The medication, a carbapenem that belongs to the ... Merrem® I.V. Sales of the name-brand product in ...
Cached Medicine Technology:Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance 2Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance 3Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.) 2Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.) 3
Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....
6 mm, 45 degree upwards, detachable....
Aaron 2250 is a multipurpose electrosurgical generator with monoploar and bi-polar functions....
Sabre 180 is a powerful niche generator....
Medicine Products: